We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPRO
1851
Open Lending Corp
LPRO
$373M
| $118K | ﹤0.01% |
19,309
+5,973
| +45% | +$34.4K |
|
1852
Tango Therapeutics
TNGX
$4.34B
| $118K | ﹤0.01% |
15,346
+2,772
| +22% | +$26.5K |
|
1853
Patria Investments
PAX
$1.72B
| $116K | ﹤0.01% |
+10,392
| New | +$123K |
|
1854
Bumble
BMBL
$367M
| $116K | ﹤0.01% |
18,155
+4,592
| +34% | +$34.6K |
|
1855
Pacific Biosciences
PACB
$422M
| $115K | ﹤0.01% |
67,793
+17,216
| +34% | +$28.3K |
|
|
XRN
1856
Chiron Real Estate Inc
XRN
$544M
| $114K | ﹤0.01% |
+2,296
| New | +$108K |
|
1857
Vaalco Energy
EGY
$594M
| $113K | ﹤0.01% |
19,685
+5,557
| +39% | +$35K |
|
1858
Genius Sports
GENI
$1.73B
| $112K | ﹤0.01% |
14,345
-4,398
| -23% | -$30.6K |
|
1859
RPC Inc
RES
$1.24B
| $112K | ﹤0.01% |
17,683
+4,599
| +35% | +$29K |
|
|
HTBK
1860
DELISTED
Heritage Commerce
HTBK
| $111K | ﹤0.01% |
+11,262
| New | +$110K |
|
|
ORC
1861
Orchid Island Capital
ORC
$1.31B
| $111K | ﹤0.01% |
+13,529
| New | +$112K |
|
|
STKL
1862
DELISTED
SunOpta
STKL
| $111K | ﹤0.01% |
17,335
+4,779
| +38% | +$28K |
|
1863
Zentalis Pharmaceuticals
ZNTL
$308M
| $110K | ﹤0.01% |
29,998
+17,814
| +146% | +$64.7K |
|
1864
Anavex Life Sciences
AVXL
$222M
| $109K | ﹤0.01% |
19,189
+4,284
| +29% | +$24.7K |
|
1865
Liquidia Corp
LQDA
$7.67B
| $109K | ﹤0.01% |
+10,893
| New | +$119K |
|
1866
Vivid Seats
SEAT
$77M
| $108K | ﹤0.01% |
1,459
+959
| +192% | +$87.4K |
|
1867
Alphatec Holdings
ATEC
$1.27B
| $108K | ﹤0.01% |
19,399
+7,045
| +57% | +$54.1K |
|
1868
Standard BioTools
LAB
$326M
| $108K | ﹤0.01% |
+55,740
| New | +$109K |
|
1869
3D Systems Corp
DDD
$420M
| $107K | ﹤0.01% |
37,787
+4,739
| +14% | +$13.6K |
|
1870
Annexon
ANNX
$855M
| $107K | ﹤0.01% |
+18,073
| New | +$107K |
|
1871
ARKO Corp
ARKO
$890M
| $107K | ﹤0.01% |
15,212
+4,493
| +42% | +$28.4K |
|
1872
Clear Channel Outdoor Holdings
CCO
$1.23B
| $107K | ﹤0.01% |
66,647
+16,396
| +33% | +$25.6K |
|
1873
NextNav
NN
$1.7B
| $106K | ﹤0.01% |
+14,177
| New | +$109K |
|
1874
Rayonier Advanced Materials
RYAM
$565M
| $104K | ﹤0.01% |
+12,098
| New | +$83.8K |
|
1875
OmniAb
OABI
$294M
| $103K | ﹤0.01% |
24,422
+4,673
| +24% | +$20.2K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.